Smith & Nephew commands a multi-billion-dollar market capitalization that fluctuates dynamically based on daily share price movements on the London Stock Exchange and New York Stock Exchange. Its valuation generally sits within the range of $11 billion to $13 billion USD, reflecting its status as a major international medical technology enterprise and a constituent member of prominent global equity benchmarks.